CompletedNCT06242535
GLY-LOW supplement study for postmenopausal women with obesity
About this title
Read the official source — NCT06242535Interventional studyAges 56+United StatesDepression
Understand this study
Who was this study for?
Listed age limits: from 56 years.
- Listed locations
- GilletteSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: July 27, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 13
- Sponsor
- Hoskinson Health and Wellness Clinic
- Sponsor type
- Hospital / academic medical center
- Study type
- Biological
- Intervention type
- Biological
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- Over 56 Years
- Official registry ID
- NCT06242535
- Official title
Show the full official title
Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Gillette
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Hoskinson Health and Wellness Clinic, a hospital or academic medical center.
Who was this study for?
Listed age limits: from 56 years.
